The mean values of serum EphA2-NF and CA19-9 were above the cut-off values for stages I and II pancreatic cancer (Fig. 3C and D; Supplementary Table S4), similar to the test cohort. This evidence concerns the gene EPHA2 and familial pancreatic carcinoma.